
GC Cell signs CDMO deal with Dewcell for stem cell-derived artificial platelets
GC Cell said it has signed a contract development and manufacturing organization (CDMO) agreement with Dewcell, a Korean biotech specializing in artificial platelet research and development, for the production of DCB-101 (en-aPLT), a stem cell-derived …